# Impact of microbial biotransformation on Zygophyllum decumbens delile through comparative metabolic insights and evaluation of antihyperglycemic and antimicrobial activities

**Authors:** Alaadin E. El-Haddad, Soad M. Abd El-Khalik, Lina J. M. Abdel-Hafez, Jaky T. Zaki, Nagwan M. Gabr

PMC · DOI: 10.1038/s41598-025-99590-9 · Scientific Reports · 2025-05-09

## TL;DR

This study shows how microbial transformation boosts the antihyperglycemic and antimicrobial effects of Zygophyllum decumbens, supporting its traditional use.

## Contribution

First report on the metabolic and biological changes in Z. decumbens after microbial biotransformation.

## Key findings

- Microbial biotransformation increased antihyperglycemic activity by 36%.
- Antimicrobial potency doubled against E. coli and P. aeruginosa.
- 27 metabolites were altered, possibly contributing to enhanced biological effects.

## Abstract

Zygophyllum is known to be used traditionally in the management of several medical conditions, including diabetes, infections, and hypertension. This study aims to monitor the effect of microbial biotransformation on both antihyperglycemic and antimicrobial activities of Zygophyllum decumbens Delile using Aspergillus niger. The metabolic profile before and after biotransformation of the ethyl acetate extract was compared using HPLC-ESI-TOF-MS/MS. Pancreatic lipase, α-amylase, and α-glucosidase in vitro inhibition assays and agar diffusion method were used to evaluate the antihyperglycemic and antimicrobial activities, respectively. Eighty-six metabolites, mainly flavonoids and phenolic acids, with a few miscellaneous metabolites, were tentatively identified in both tested extracts. A 36% potentiation in antihyperglycemic activity was observed following microbial biotransformation. Regarding antimicrobial activity, the minimum inhibitory concentration (MIC) against both E. coli and P. aeruginosa decreased from 0.62 to 0.31 mg/ml, representing a nearly 50% reduction. It was noticed that microbial biotransformation altered 27 of the identified metabolites, which may contribute to the enhanced biological activities detected. The study depicts the first report of metabolic profiles and biological differences of Z. decumbens before and after biotransformation. It also validates the traditional use of Z. decumbens for hyperglycemia and its potential as a natural antimicrobial source.

The online version contains supplementary material available at 10.1038/s41598-025-99590-9.

## Linked entities

- **Chemicals:** ethyl acetate (PubChem CID 8857)
- **Diseases:** diabetes (MONDO:0005015), hyperglycemia (MONDO:0002909)
- **Species:** Escherichia coli (taxon 562), Pseudomonas aeruginosa (taxon 287), Aspergillus niger (taxon 5061)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), hypertension (MESH:D006973), hyperglycemia (MESH:D006943), infections (MESH:D007239)
- **Chemicals:** phenolic acids (MESH:C017616), agar (MESH:D000362), flavonoids (MESH:D005419), ethyl acetate (MESH:C007650)
- **Species:** Tetraena decumbens (species) [taxon 90542], Escherichia coli (E. coli, species) [taxon 562], Aspergillus niger (species) [taxon 5061], Pseudomonas aeruginosa (species) [taxon 287]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12064765/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12064765/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12064765/full.md

---
Source: https://tomesphere.com/paper/PMC12064765